BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24818527)

  • 21. Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease.
    Küçükaycan M; Van Krugten M; Pennings HJ; Huizinga TW; Buurman WA; Dentener MA; Wouters EF
    Respir Res; 2002; 3(1):29. PubMed ID: 12537602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
    Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
    Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenet Genomics; 2014 Apr; 24(4):220-9. PubMed ID: 24535486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of recombinant human tumor necrosis factor-Fc on pulmonary function in a rat model of chronic obstructive pulmonary disease].
    Zhang C; Chen P; Cai S; Chen JB; Wu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):432-6. PubMed ID: 17673016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-8 gene variants are associated with lung function decline and multidimensional BODE index in COPD patients but not with disease susceptibility: a validation study.
    Córdoba-Lanús E; Baz-Dávila R; Espinoza-Jiménez A; Rodríguez-Pérez MC; Varo N; de-Torres JP; González-Almeida D; Aguirre-Jaime A; Casanova C
    COPD; 2015 Feb; 12(1):55-61. PubMed ID: 24946112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner.
    Chiang CH; Chuang CH; Liu SL
    Lung; 2014 Feb; 192(1):95-102. PubMed ID: 24153451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers.
    Tanaka G; Sandford AJ; Burkett K; Connett JE; Anthonisen NR; Paré PD; He JQ
    Eur Respir J; 2007 Jan; 29(1):34-41. PubMed ID: 16971410
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Reséndiz-Hernández JM; Ambrocio-Ortiz E; Pérez-Rubio G; López-Flores LA; Abarca-Rojano E; Pavón-Romero GF; Flores-Trujillo F; de Jesús Hernández-Zenteno R; Camarena Á; Pérez-Rodríguez M; Salazar AM; Ramírez-Venegas A; Falfán-Valencia R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():627-637. PubMed ID: 29497291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease.
    Higham MA; Pride NB; Alikhan A; Morrell NW
    Eur Respir J; 2000 Feb; 15(2):281-4. PubMed ID: 10706492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
    Dahl M; Tybjaerg-Hansen A; Vestbo J; Lange P; Nordestgaard BG
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1008-11. PubMed ID: 11587987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination and clinical implication of leukotriene B(4) and tumor necrosis factor-alpha in condensate of exhaled breath of chronic obstructive pulmonary disease patients].
    Chen JL; Chen JR; Tao YJ; Cai YY; Tao GH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jun; 20(6):357-60. PubMed ID: 18549718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease.
    Chen YC; Liu SF; Chin CH; Wu CC; Chen CJ; Chang HW; Wang YH; Chung YH; Chao TY; Lin MC
    Lung; 2010 Aug; 188(4):339-47. PubMed ID: 20352242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
    Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
    Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study.
    Tashkin DP; Rabinoff M; Noble EP; Ritchie TL; Simmons MS; Connett J
    COPD; 2012 Dec; 9(6):620-8. PubMed ID: 22958175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.
    Golpe R; Sanjuán López P; Cano Jiménez E; Castro Añón O; Pérez de Llano LA
    Arch Bronconeumol; 2014 Aug; 50(8):318-24. PubMed ID: 24576449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
    Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
    Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease.
    Xiao D; Wang C; Du MJ; Pang BS; Zhang HY; Xiao B; Liu JZ; Weng XZ; Su L; Christiani DC
    Chin Med J (Engl); 2004 May; 117(5):661-7. PubMed ID: 15161530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of cachexia and related components on pulmonary functions in patients with COPD.
    Görek Dilektaşli A; Ulubay G; Bayraktar N; Eminsoy I; Oner Eyüboğlu F
    Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.